Catharina Svanborg#

Catharina Svanborg, MD serves as Chief Scientific Officer of HAMLET Pharma AB. Dr. Svanborg is currently Professor of Clinical Immunology at Lund University physician, and Chief Physician at the Lund University Hospital. Dr. Svanborg founded HAMLET Pharma which was acquired by NatImmune in 2006. She has been Director of Medivir AB since 2003 and serves as Director of HAMLET Pharma AB. She serves as Board member of IVA, the Royal Swedish Academy of Engineering Sciences, Board member PkC of the Swedish Cancer Society. She serves as a Member of Scientific Advisory Board of NatImmune A/S. She has been honoured with a number of awards and visiting professorships. Dr. Svanborg has authored and co-authored more that 400 papers, mainly within microbial pathogenesis and innate immunity with urinary tract infections as a model as well as HAMLET, a tumoricidal complex of partially unfolded alpha-lactlbumin and oleic acid. She holds a MD from University of Gothenburg and with a PhD from University of Michigan.

Imprint Privacy policy « This page (revision-1) was last updated on Monday, 10. December 2012, 13:23 by Nowak Aleksandra
  • operated by